US NeuroSurgical Holdings Inc
For the period ended Dec 31, 2023. Filed Apr 5, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 5, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 11. Executive Compensation
| Item 11. | Executive Compensation. |
|---|
The information below sets forth the compensation for the years ended December 31, 2023, 2022, and 2021 for the President of the Company.
Summary Compensation Table
| Name and Principal Position | Annual Compensation | |
|---|---|---|
| Year | Salary | |
| Alan Gold | 2023 | $125,000 |
| President & Chairman | 2022 | $188,000 |
| of the Board | 2021 | $300,000 |
Employee Benefits; Employment Agreement
Mr. Gold was entitled to reimbursement of up to $1,000 per month for automobile expenses, which arrangement ceased in September 2023. In addition, as with other full-time employees, Mr. Gold was entitled to participate in the Company’s health and life insurance program. The Company, however, terminated its the health insurance policies in February 2024. The Company also paid the premiums in 2023 for a life insurance policy on Mr. Golf in the amount of $500,000, naming Mr. Gold’s wife as beneficiary.
The Company and Mr. Gold are parties to an employment agreement giving either party the option to terminate employment by giving the other party six-months written notice.
Director Compensation
Through March 31, 2023, our directors, who are not officers or employees, were paid a monthly retainer of $3,000. Monthly payments were reduced to $2,000 beginning in April 2023. Mr. Leimkuhler received aggregate cash payments of $31,000 in 2023. During 2023, Mr. St. Lawrence received aggregate cash payments of $12,000 and a grant of 50,000 shares of the Company’s Common Stock, which had a per share fair market value of approximately $4,500 at the time of grant. Mr. Merriman declined compensation for serving as a director during 2023. Directors of the Company who are officers or employees do not receive any additional compensation for serving on the Board.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.